Cytek Biosciences Stock Price Prediction
| CTKB Stock | USD 3.21 0.11 3.55% |
Momentum 52
Impartial
Oversold | Overbought |
Quarterly Earnings Growth 0.735 | EPS Estimate Next Quarter 0.01 | EPS Estimate Current Year (0.01) | EPS Estimate Next Year 0.07 | Wall Street Target Price 5.75 |
Using Cytek Biosciences hype-based prediction, you can estimate the value of Cytek Biosciences from the perspective of Cytek Biosciences response to recently generated media hype and the effects of current headlines on its competitors. We also analyze overall investor sentiment towards Cytek Biosciences using Cytek Biosciences' stock options and short interest. It helps to benchmark the overall future attitude of investors towards Cytek using crowd psychology based on the activity and movement of Cytek Biosciences' stock price.
Cytek Biosciences Short Interest
A significant increase or decrease in Cytek Biosciences' short interest from the previous month could be a good indicator of investor sentiment towards Cytek. Short interest can provide insight into the potential direction of Cytek Biosciences stock and how bullish or bearish investors feel about the market overall.
200 Day MA 4.7444 | Short Percent 0.0523 | Short Ratio 3.45 | Shares Short Prior Month 5.1 M | 50 Day MA 3.1557 |
Cytek Biosciences Hype to Price Pattern
Investor biases related to Cytek Biosciences' public news can be used to forecast risks associated with an investment in Cytek. The trend in average sentiment can be used to explain how an investor holding Cytek can time the market purely based on public headlines and social activities around Cytek Biosciences. Please note that most equities that are difficult to arbitrage are affected by market sentiment the most.
Some investors profit by finding stocks that are overvalued or undervalued based on market sentiment. The correlation of Cytek Biosciences' market sentiment to its price can help taders to make decisions based on the overall investors consensus about Cytek Biosciences.
Cytek Biosciences Implied Volatility | 4.16 |
Cytek Biosciences' implied volatility exposes the market's sentiment of Cytek Biosciences stock's possible movements over time. However, it does not forecast the overall direction of its price. In a nutshell, if Cytek Biosciences' implied volatility is high, the market thinks the stock has potential for high price swings in either direction. On the other hand, the low implied volatility suggests that Cytek Biosciences stock will not fluctuate a lot when Cytek Biosciences' options are near their expiration.
The fear of missing out, i.e., FOMO, can cause potential investors in Cytek Biosciences to buy its stock at a price that has no basis in reality. In that case, they are not buying Cytek because the equity is a good investment, but because they need to do something to avoid the feeling of missing out. On the other hand, investors will often sell stocks at prices well below their value during bear markets because they need to stop feeling the pain of losing money.
Cytek Biosciences after-hype prediction price | USD 3.11 |
There is no one specific way to measure market sentiment using hype analysis or a similar predictive technique. This prediction method should be used in combination with more fundamental and traditional techniques such as stock price forecasting, technical analysis, analysts consensus, earnings estimates, and various momentum models.
Check out Cytek Biosciences Basic Forecasting Models to cross-verify your projections. Cytek Biosciences After-Hype Price Prediction Density Analysis
As far as predicting the price of Cytek Biosciences at your current risk attitude, this probability distribution graph shows the chance that the prediction will fall between or within a specific range. We use this chart to confirm that your returns on investing in Cytek Biosciences or, for that matter, your successful expectations of its future price, cannot be replicated consistently. Please note, a large amount of money has been lost over the years by many investors who confused the symmetrical distributions of Stock prices, such as prices of Cytek Biosciences, with the unreliable approximations that try to describe financial returns.
Next price density |
| Expected price to next headline |
Cytek Biosciences Estimiated After-Hype Price Volatility
In the context of predicting Cytek Biosciences' stock value on the day after the next significant headline, we show statistically significant boundaries of downside and upside scenarios based on Cytek Biosciences' historical news coverage. Cytek Biosciences' after-hype downside and upside margins for the prediction period are 0.16 and 8.30, respectively. We have considered Cytek Biosciences' daily market price in relation to the headlines to evaluate this method's predictive performance. Remember, however, there is no scientific proof or empirical evidence that news-based prediction models outperform traditional linear, nonlinear models or artificial intelligence models to provide accurate predictions consistently.
Current Value
Cytek Biosciences is risky at this time. Analysis and calculation of next after-hype price of Cytek Biosciences is based on 3 months time horizon.
Cytek Biosciences Stock Price Prediction Analysis
Have you ever been surprised when a price of a Company such as Cytek Biosciences is soaring high without any particular reason? This is usually happening because many institutional investors are aggressively trading Cytek Biosciences backward and forwards among themselves. Have you ever observed a lot of a particular company's price movement is driven by press releases or news about the company that has nothing to do with actual earnings? Usually, hype to individual companies acts as price momentum. If not enough favorable publicity is forthcoming, the Stock price eventually runs out of speed. So, the rule of thumb here is that as long as this news hype has nothing to do with immediate earnings, you should pay more attention to it. If you see this tendency with Cytek Biosciences, there might be something going there, and it might present an excellent short sale opportunity.
| Expected Return | Period Volatility | Hype Elasticity | Related Elasticity | News Density | Related Density | Expected Hype |
0.18 | 5.19 | 0.01 | 0.06 | 8 Events / Month | 6 Events / Month | In about 8 days |
| Latest traded price | Expected after-news price | Potential return on next major news | Average after-hype volatility | ||
3.21 | 3.11 | 0.32 |
|
Cytek Biosciences Hype Timeline
Cytek Biosciences is currently traded for 3.21. The entity has historical hype elasticity of 0.01, and average elasticity to hype of competition of 0.06. Cytek is forecasted to increase in value after the next headline, with the price projected to jump to 3.11 or above. The average volatility of media hype impact on the company the price is over 100%. The price jump on the next news is projected to be 0.32%, whereas the daily expected return is currently at -0.18%. The volatility of related hype on Cytek Biosciences is about 1520.88%, with the expected price after the next announcement by competition of 3.27. The company reported the previous year's revenue of 200.45 M. Net Loss for the year was (6.02 M) with profit before overhead, payroll, taxes, and interest of 108.25 M. Given the investment horizon of 90 days the next forecasted press release will be in about 8 days. Check out Cytek Biosciences Basic Forecasting Models to cross-verify your projections.Cytek Biosciences Related Hype Analysis
Having access to credible news sources related to Cytek Biosciences' direct competition is more important than ever and may enhance your ability to predict Cytek Biosciences' future price movements. Getting to know how Cytek Biosciences' peers react to changing market sentiment, related social signals, and mainstream news is a great way to find investing opportunities and time the market. The summary table below summarizes the essential lagging indicators that can help you analyze how Cytek Biosciences may potentially react to the hype associated with one of its peers.
| HypeElasticity | NewsDensity | SemiDeviation | InformationRatio | PotentialUpside | ValueAt Risk | MaximumDrawdown | |||
| MXCT | MaxCyte | (0.24) | 8 per month | 0.00 | (0.12) | 5.96 | (5.80) | 18.72 | |
| SGHT | Sight Sciences | (0.17) | 9 per month | 4.50 | 0.09 | 7.36 | (4.92) | 25.67 | |
| CVRX | CVRx Inc | (0.09) | 6 per month | 7.31 | 0.08 | 11.74 | (5.03) | 50.43 | |
| NPCE | Neuropace | (0.02) | 2 per month | 0.00 | (0.03) | 5.22 | (5.92) | 48.86 | |
| RPID | Rapid Micro Biosystems | 0.07 | 7 per month | 3.32 | 0.12 | 8.12 | (5.19) | 35.51 | |
| AKYA | Akoya Biosciences | 2.59 | 8 per month | 5.25 | 0.02 | 9.73 | (8.80) | 32.35 | |
| RXST | Rxsight | 0.49 | 8 per month | 0.00 | (0.16) | 6.42 | (5.79) | 52.85 | |
| DSGN | Design Therapeutics | 0.1 | 8 per month | 5.04 | 0.06 | 8.13 | (8.26) | 27.45 |
Cytek Biosciences Additional Predictive Modules
Most predictive techniques to examine Cytek price help traders to determine how to time the market. We provide a combination of tools to recognize potential entry and exit points for Cytek using various technical indicators. When you analyze Cytek charts, please remember that the event formation may indicate an entry point for a short seller, and look at other indicators across different periods to confirm that a breakdown or reversion is likely to occur.| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
About Cytek Biosciences Predictive Indicators
The successful prediction of Cytek Biosciences stock price could yield a significant profit to investors. But is it possible? The efficient-market hypothesis suggests that all published stock prices of traded companies, such as Cytek Biosciences, already reflect all publicly available information. This academic statement is a fundamental principle of many financial and investing theories used today. However, the typical investor usually disagrees with a 'textbook' version of this hypothesis and continually tries to find mispriced stocks to increase returns. We use internally-developed statistical techniques to arrive at the intrinsic value of Cytek Biosciences based on analysis of Cytek Biosciences hews, social hype, general headline patterns, and widely used predictive technical indicators.
We also calculate exposure to Cytek Biosciences's market risk, different technical and fundamental indicators, relevant financial multiples and ratios, and then comparing them to Cytek Biosciences's related companies. | 2022 | 2023 | 2024 | 2025 (projected) | Payables Turnover | 13.12 | 27.57 | 16.16 | 13.25 | Days Of Inventory On Hand | 278.71 | 265.83 | 179.31 | 256.5 |
Story Coverage note for Cytek Biosciences
The number of cover stories for Cytek Biosciences depends on current market conditions and Cytek Biosciences' risk-adjusted performance over time. The coverage that generates the most noise at a given time depends on the prevailing investment theme that Cytek Biosciences is classified under. However, while its typical story may have numerous social followers, the rapid visibility can also attract short-sellers, who usually are skeptical about Cytek Biosciences' long-term prospects. So, having above-average coverage will typically attract above-average short interest, leading to significant price volatility.
Contributor Headline
Latest Perspective From Macroaxis
Cytek Biosciences Short Properties
Cytek Biosciences' future price predictability will typically decrease when Cytek Biosciences' long traders begin to feel the short-sellers pressure to drive the price lower. The predictive aspect of Cytek Biosciences often depends not only on the future outlook of the potential Cytek Biosciences' investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. Cytek Biosciences' indicators that are reflective of the short sentiment are summarized in the table below.
| Common Stock Shares Outstanding | 130.6 M | |
| Cash And Short Term Investments | 277.9 M |
Complementary Tools for Cytek Stock analysis
When running Cytek Biosciences' price analysis, check to measure Cytek Biosciences' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Cytek Biosciences is operating at the current time. Most of Cytek Biosciences' value examination focuses on studying past and present price action to predict the probability of Cytek Biosciences' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Cytek Biosciences' price. Additionally, you may evaluate how the addition of Cytek Biosciences to your portfolios can decrease your overall portfolio volatility.
| Bollinger Bands Use Bollinger Bands indicator to analyze target price for a given investing horizon | |
| Portfolio Anywhere Track or share privately all of your investments from the convenience of any device | |
| AI Portfolio Architect Use AI to generate optimal portfolios and find profitable investment opportunities | |
| Content Syndication Quickly integrate customizable finance content to your own investment portal |